logo
  

JinkoSolar Slips To Loss In Q4; Sees Q1 Revenue Below View - Quick Facts

JinkoSolar Holding Co., Ltd. (JKS) reported that its net loss attributable to the company's ordinary shareholders was RMB377.0 million or US$57.8 million for the fourth quarter of 2020, compared to net income of RMB369.5 million in the fourth quarter of 2019. Loss per ADS was RMB14.40 or US$2.21, compared to earnings per ADS of RMB6.68 last year.

In Friday pre-market trade, JKS was trading at $35.31 down $3.55 or 9.14 percent.

Non-GAAP earnings per ADS were RMB0.74 or US$0.11 compared to RMB 9.74 in the prior year.

Total revenues in the fourth quarter of 2020 were RMB9.42 billion or US$1.44 billion, a decrease of 1.1% from RMB9.53 billion in the fourth quarter of 2019.

Analysts polled by Thomson Reuters expect the company to report earnings of $0.37 per share and revenues of $1.38 billion for the fourth-quarter. Analysts' estimates typically exclude special items.

For the first quarter of 2021, the company expects total solar module shipments to be in the range of 4.5 GW to 5.0 GW, and total revenue of US$1.18 billion to US$1.30 billion. Analysts expect revenues of $1.31 billion for the first-quarter.

For full year 2021, the company estimates total shipments, including solar cell and wafer, to be in the range of 25 GW to 30 GW.

JinkoSolar expects its annual mono wafer, solar cell and solar module production capacity to reach 33 GW, 27 GW, including 800 MW N-type cells, and 37 GW, respectively, by the end of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
Follow RTT